Improving the outcome of pneumococcal meningitis

Archives of Disease in Childhood

Volumn 90, Issue 4, 2005, Pages 333-334

  Pelton, S I ^a,b   Yogev, R ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CEFOTAXIME; CEFTRIAXONE; CORTICOSTEROID; DEXAMETHASONE; INTERLEUKIN 10; NITRIC OXIDE SYNTHASE INHIBITOR; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; CHILDHOOD DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFLAMMATION; MORBIDITY; MORTALITY; NEUROLOGICAL COMPLICATION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; DEXAMETHASONE; HUMANS; INFANT; INFANT, NEWBORN; MENINGITIS, PNEUMOCOCCAL; TREATMENT OUTCOME;

EID: 16844385091     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.052928     Document Type: Review

References (20)

1. McIntyre PD, MacIntyre CR, Gilmour R, et al. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child 2005;90:391-6.
2. Lebel MH, McCracken GH. Delayed cerebraspinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics 1989;83:161-7.
3. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after porenteral antibiotic pretreatment. Pediatrics 2001;108:1169-74.
4. van der Flier M, Geelen SP, Kimpen JL, et al. Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev 2003;16:415-29.
5. Mustafa MM, Ramilo O, Sawz-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990;144:883-7.
6. Wald ER, Kaplan SL, Mason EO, et al. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group. Pediatrics 1995;95:21-8.
7. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31.
8. Kanra GY, Ozen H, Secmeer G, et al. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995;14:490-4.
9. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis 1999;8:848-51.
10. Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087-97.
11. Buckingham SC, McCullers JA, Lujan-Zilbermann J, et al. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J 2001;20:837-43.
12. Feigen RD. Use of corticosteroids in bacterial meningitis. Pediatr Infect Dis J 2004;23:355-7.
13. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995;39:1988-92.
14. Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin resistant Stretpococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother 1997;41:1888-91.
15. Bradley JSS, Farhat C, Stamboulian D, et al. Ceftriaxone therapy of bacterial meningitis: cerebrospinal fluid concentrations and bactericidal activity after intramuscular injection in children treated with dexamethasone. Pediatr Infect Dis J 1994;13:724-8.
16. Quagliarello VJ, Scheid WM. Treatment of bacterial meningitis. N Engl J Med 1997;336:708-16.
17. Kirsten Møller, Peter Skinhoj. Guidelines for managing acute bacterial meningitis. BMJ 2000;320:1290.
18. Leib SL, Heimgartner C, Bifrafe YD, et al. Dexamethasone aggravates hippocampol apoptosis and learning deficiency in pneumococal meningitis in infants rats. Pediatr Res 2003;54:353-7.
19. Zysk G, Bruck W, Gerber J, et al. Anti-inflammatory treatment influences neuronal apoptotic cell death in the denote gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996;55:722-8.
20. American Academy of Pediatrics. Pneumococcal infections. In: Pickering L, ed. 2003 Report of the Committee on Infectious Diseases. 26th edn. Elk Grave Village, IL, 2003:493.